Apnimed director Chris Dimitropoulos reports no holdings
Apnimed, Inc. (symbol APMD) reported that Chris Dimitropoulos is a director and filed an initial statement of beneficial ownership on Form 3.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Apnimed, Inc. (symbol APMD) reported that Chris Dimitropoulos is a director and filed an initial statement of beneficial ownership on Form 3. The filing lists no reportable holdings or transactions in Apnimed securities at this time and references an Exhibit 24 Power of Attorney.
Key Terms
Form 3 regulatory
beneficial ownership financial
Power of Attorney regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filed for APMD by Chris Dimitropoulos disclose?
Are there any buy or sell transactions reported in this APMD Form 3?
What role does Chris Dimitropoulos have at Apnimed, Inc. (APMD)?
What is the significance of the Exhibit 24 Power of Attorney in the APMD Form 3?
AI-generated analysis. How Rhea-AI works. Not financial advice.